Publications
Detailed Information
Genetic Polymorphism of Geranylgeranyl Diphosphate Synthase (GGSP1) Predicts Bone Density Response to Bisphosphonate Therapy in Korean Women
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Choi, Hyung Jin | - |
dc.contributor.author | Choi, Ji Yeob | - |
dc.contributor.author | Cho, Sun Wook | - |
dc.contributor.author | Kang, Daehee | - |
dc.contributor.author | Kim, Sang Wan | - |
dc.contributor.author | Chung, Yoon-Sok | - |
dc.contributor.author | Shin, Chan Soo | - |
dc.contributor.author | Kim, Seong Yeon | - |
dc.contributor.author | Han, Ki Ok | - |
dc.date.accessioned | 2012-05-29T02:09:43Z | - |
dc.date.available | 2012-05-29T02:09:43Z | - |
dc.date.issued | 2010-03-01 | - |
dc.identifier.citation | YONSEI MEDICAL JOURNAL; Vol.51 2; 231-238 | ko_KR |
dc.identifier.issn | 0513-5796 | - |
dc.identifier.uri | https://hdl.handle.net/10371/76518 | - |
dc.description.abstract | Purpose: Genetic factor is an important predisposing element influencing the susceptibility to osteoporosis and related complications. The purpose of the present study is to investigate whether genetic polymorphisms of farnesyl diphosphate synthase (FDPS) or geranylgeranyl diphosphate synthase (GGPS) genes were associated with the response to bisphosphonate therapy. Materials and Methods: In the present study, 144 Korean women with osteoporosis were included. Among 13 genetic polymorphisms found within the FDPS and GGPS1 gene, 4 genetic polymorphisms with frequencies > 5% were selected for further study. Bone mineral density (BMD) response after 1 year treatment of bisphosphonate therapy was analyzed according to the genotypes. Results: Women with 2 deletion allele of GGPS1 -8188A ins/del (rs3840452) had significantly higher femoral neck BMD at baseline compared with those with one or no deletion allele (0.768 +/- 0.127 vs. 0.695 +/- 0.090 respectively; p = 0.041). The response rate of women with 2 deletion allele of GGPS1 -8188A ins/del (28.6%) was significantly lower than the rate of women with one (81.4%) or no deletion allele (75.0%) (p = 0.011). Women with 2 deletion allele of GGPS1 -8188A ins/del had 7-fold higher risk of non-response to bisphosphonate therapy compared with women with other genotypes in GGPS1 -8188 after adjusting for baseline BMD (OR = 7.48; 95% CI = 1.3242.30; p = 0.023). Other polymorphisms in FDPS or GGPS1 were not associated with lumbar spine BMD or femoral neck BMD. Conclusion: Our Study suggested that GGPS1 -8188A ins/del polymorphism may confer susceptibility to femoral heck BMD response to bisphosphonate therapy in Korean women. However, further study should be done to confirm the results in a larger population. | ko_KR |
dc.description.sponsorship | This work was supported by a grant from Ministry of
Health, Welfare and Family of Korea (03-PJ10-PG13- GD01-0002). | ko_KR |
dc.language.iso | en | ko_KR |
dc.publisher | YONSEI UNIV COLLEGE MEDICINE | ko_KR |
dc.subject | Polymorphism | ko_KR |
dc.subject | osteoporosis | ko_KR |
dc.subject | bisphosphonate | ko_KR |
dc.title | Genetic Polymorphism of Geranylgeranyl Diphosphate Synthase (GGSP1) Predicts Bone Density Response to Bisphosphonate Therapy in Korean Women | ko_KR |
dc.type | Article | ko_KR |
dc.contributor.AlternativeAuthor | 최형진 | - |
dc.contributor.AlternativeAuthor | 최지엽 | - |
dc.contributor.AlternativeAuthor | 조선욱 | - |
dc.contributor.AlternativeAuthor | 강대희 | - |
dc.contributor.AlternativeAuthor | 한기옥 | - |
dc.contributor.AlternativeAuthor | 김상완 | - |
dc.contributor.AlternativeAuthor | 김성연 | - |
dc.contributor.AlternativeAuthor | 정윤속 | - |
dc.contributor.AlternativeAuthor | 신찬수 | - |
dc.identifier.doi | 10.3349/ymj.2010.51.2.231 | - |
dc.citation.journaltitle | YONSEI MEDICAL JOURNAL | - |
dc.description.citedreference | Guo RT, 2007, P NATL ACAD SCI USA, V104, P10022, DOI 10.1073/pnas.0702254104 | - |
dc.description.citedreference | Gallagher JC, 2006, BONE, V39, P1268, DOI 10.1016/j.bone.2006.06.007 | - |
dc.description.citedreference | Bonnick S, 2006, J CLIN ENDOCR METAB, V91, P2631, DOI 10.1210/jc.2005-2602 | - |
dc.description.citedreference | BONNICK SL, 2006, AM J MED S1, V119, pS25 | - |
dc.description.citedreference | Kim SW, 2005, ENDOCR J, V52, P667 | - |
dc.description.citedreference | Palomba S, 2005, OSTEOPOROSIS INT, V16, P943, DOI 10.1007/s00198-004-1800-5 | - |
dc.description.citedreference | Lewiecki EM, 2003, J CLIN DENSITOM, V6, P307 | - |
dc.description.citedreference | Palomba S, 2003, CLIN ENDOCRINOL, V58, P365 | - |
dc.description.citedreference | Qureshi AM, 2002, CALCIFIED TISSUE INT, V70, P158 | - |
dc.description.citedreference | Turner CH, 2002, OSTEOPOROSIS INT, V13, P97 | - |
dc.description.citedreference | Mann V, 2001, J CLIN INVEST, V107, P899 | - |
dc.description.citedreference | Keen RW, 2001, RHEUMATOLOGY, V40, P48 | - |
dc.description.citedreference | Bergstrom JD, 2000, ARCH BIOCHEM BIOPHYS, V373, P231 | - |
dc.description.citedreference | Crilly RG, 2000, OSTEOPOROSIS INT, V11, P607 | - |
dc.description.citedreference | Eisman JA, 1999, ENDOCR REV, V20, P788 | - |
dc.description.citedreference | Tsukamoto K, 1999, J HUM GENET, V44, P148 | - |
dc.description.citedreference | Keen RW, 1998, BONE, V23, P367 | - |
dc.description.citedreference | Masi L, 1998, BIOCHEM BIOPH RES CO, V248, P190 | - |
dc.description.citedreference | Uitterlinden AG, 1998, NEW ENGL J MED, V338, P1016 | - |
dc.description.citedreference | Mizunuma H, 1997, BONE, V21, P379 | - |
dc.description.citedreference | Kurland ES, 1997, J CLIN ENDOCR METAB, V82, P2799 | - |
dc.description.citedreference | Shiraki M, 1997, J BONE MINER RES, V12, P1438 | - |
dc.description.citedreference | Sainz J, 1997, NEW ENGL J MED, V337, P77 | - |
dc.description.citedreference | Johnson ML, 1997, AM J HUM GENET, V60, P1326 | - |
dc.description.citedreference | Langdahl BL, 1997, BONE, V20, P289 | - |
dc.description.citedreference | SILVERMAN SL, 1992, CALCIFIED TISSUE INT, V50, P101 | - |
dc.description.tc | 1 | - |
- Appears in Collections:
- Files in This Item:
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.